iShares LifePath Target Date 2045 ETF (NYSEARCA:ITDE – Get Free Report) was the target of a significant increase in short interest in the month of February. As of February 13th, there was short interest totaling 19,961 shares, an increase of 70.7% from the January 29th total of 11,695 shares. Based on an average daily volume of 13,897 shares, the short-interest ratio is presently 1.4 days. Approximately 1.3% of the company’s shares are sold short. Approximately 1.3% of the company’s shares are sold short. Based on an average daily volume of 13,897 shares, the short-interest ratio is presently 1.4 days.
Institutional Trading of iShares LifePath Target Date 2045 ETF
Large investors have recently bought and sold shares of the business. Geneos Wealth Management Inc. bought a new position in iShares LifePath Target Date 2045 ETF in the first quarter valued at approximately $34,000. Capital Advisors Ltd. LLC bought a new stake in shares of iShares LifePath Target Date 2045 ETF in the 4th quarter valued at about $53,000. Sunbelt Securities Inc. lifted its stake in iShares LifePath Target Date 2045 ETF by 2,054.5% in the 3rd quarter. Sunbelt Securities Inc. now owns 2,607 shares of the company’s stock valued at $94,000 after purchasing an additional 2,486 shares during the last quarter. Finally, Susquehanna International Group LLP grew its holdings in iShares LifePath Target Date 2045 ETF by 38.4% during the third quarter. Susquehanna International Group LLP now owns 9,001 shares of the company’s stock worth $323,000 after purchasing an additional 2,496 shares during the period.
iShares LifePath Target Date 2045 ETF Stock Down 0.6%
NYSEARCA ITDE traded down $0.23 on Monday, reaching $37.70. The company had a trading volume of 5,844 shares, compared to its average volume of 15,702. The stock’s 50 day moving average is $37.16 and its 200-day moving average is $36.34. The stock has a market cap of $58.81 million, a price-to-earnings ratio of 20.03 and a beta of 0.82. iShares LifePath Target Date 2045 ETF has a 52 week low of $27.42 and a 52 week high of $38.24.
iShares LifePath Target Date 2045 ETF Company Profile
The iShares LifePath Target Date 2045 ETF USD (ITDE) is an exchange-traded fund that mostly invests in target date asset allocation. The fund is an actively managed fund-of-funds that invests in equity, fixed income, and money market ETFs using an asset allocation strategy that shifts exposure as the target retirement date approaches. The fund is intended for investors who anticipate retiring around 2045 ITDE was launched on Oct 17, 2023 and is issued by BlackRock.
Recommended Stories
- Five stocks we like better than iShares LifePath Target Date 2045 ETF
- ATCX is Sitting on One of Brazil’s Largest Critical Minerals Portfolios!
- A Rockefeller Moment Is Unfolding in Rare Earths
- Silver Crossed $100: Is the $500 surge next? (Join us March 4)
- 1,500 Banks Just Handed the Fed Your Bank Account
- America’s 1776 happening again
Receive News & Ratings for iShares LifePath Target Date 2045 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares LifePath Target Date 2045 ETF and related companies with MarketBeat.com's FREE daily email newsletter.
